Clinical Trial Imaging Services Market Size, Share, Trends, Growth and Forecast Report 2021-2027

Description

The global Clinical Trial Imaging Services market garnered revenue around USD 3,411 million in 2020 and projected to reach USD 2,911.69 million in 2027, with at a compound annual growth rate (CAGR) 6.7% throughout the estimate period from 2021 to 2027. Clinical trial imaging services are defined as the set of services offered by the contract research organizations (CROs), which are used to conduct imaging in clinical trials. Furthermore, CROs provide these services to the pharmaceutical, biotechnology, medical device companies, and others. These companies use the services to outsource imaging related functions of a clinical trial. Furthermore, some of the services offered in the market include project and data management services, quality control, image analysis, and others. For instance, through analytical services, the CROs manage the acquisition and transfer of images, review of images, and others. Thus, a team of radiological experts is employed to provide the image analysis. Similarly, services such as project management include a team of experts, which have the experience of handling the workflow of a clinical trial. Furthermore, these services are offered for different types of therapeutic expertise such as oncology, neurology, endocrinology, and others.

This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.

The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Clinical Trial Imaging Services market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Clinical Trial Imaging Services market growth.

The global Clinical Trial Imaging Services market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.

Major manufacturers analysed under this study comprises:

The global clinical trial imaging services market is highly competitive and the prominent players in the market have adopted various strategies to garner maximum clinical trial imaging services market share. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market include BioClinica, Inc., Biospective Inc., Calyx, ERT Clinical, Icon Plc, IXICO plc, Intrinsic Imaging LLC, Imaging Endpoints, Micron Inc, Median Technologies, Medpace Inc., Pharmtrace, and ProScan Imaging.

This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:

By Service Type

·         Clinical Trial Design & Consultation Services

·         Reading & Analytical Services 

·         Operational Imaging Services

·         Project & Data Management Services

·         Others 

By End User 

·         Pharmaceutical & Biotechnology Companies

·         Medical Device Manufacturers

·         Academic & Government Research Institutes

By Therapeutic Area

·         Oncology

·         Neurology

·         Endocrinology

·         Cardiology

·         Gastroenterology

·         Others

Regional Analysis and Forecast

Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:

North America

United States

Canada

 

Europe

Germany

United Kingdom

Italy

France

Rest of EU

 

Asia Pacific

China

India

Japan

Southeast Asia

Rest of APAC

 

Central & South America 

Brazil 

Argentina

Rest of Central & South America 

 

Middle East and Africa

GCC

North Africa

South Africa

TABLE OF CONTENT

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Clinical Trial Imaging Services Market, By Service Type

7.1.  Clinical Trial Imaging Services Market, by Service Type, 2021-2027

7.1.1.    Clinical Trial Design & Consultation Services

7.1.1.1.        Market Revenue and Forecast (2016-2027)

7.1.2.    Reading & Analytical Services

7.1.2.1.        Market Revenue and Forecast (2016-2027)

7.1.3.    Operational Imaging Services

7.1.3.1.        Market Revenue and Forecast (2016-2027)

7.1.4.    Project & Data Management Services

7.1.4.1.        Market Revenue and Forecast (2016-2027)

7.1.5.    Others

7.1.5.1.        Market Revenue and Forecast (2016-2027)

Chapter 8.  Global Clinical Trial Imaging Services Market, By End User

8.1.  Clinical Trial Imaging Services Market, by End User, 2021-2027

8.1.1.    Pharmaceutical & Biotechnology Companies

8.1.1.1.        Market Revenue and Forecast (2016-2027)

8.1.2.    Medical Device Manufacturers

8.1.2.1.        Market Revenue and Forecast (2016-2027)

8.1.3.    Academic & Government Research Institutes

8.1.3.1.        Market Revenue and Forecast (2016-2027)

Chapter 9.  Global Clinical Trial Imaging Services Market, By Therapeutic Area

9.1.  Clinical Trial Imaging Services Market, by Therapeutic Area, 2021-2027

9.1.1.    Oncology

9.1.1.1.        Market Revenue and Forecast (2016-2027)

9.1.2.    Neurology

9.1.2.1.        Market Revenue and Forecast (2016-2027)

9.1.3.    Endocrinology

9.1.3.1.        Market Revenue and Forecast (2016-2027)

9.1.4.    Cardiology

9.1.4.1.        Market Revenue and Forecast (2016-2027)

9.1.5.    Gastroenterology

9.1.5.1.        Market Revenue and Forecast (2016-2027)

9.1.6.    Others

9.1.6.1.        Market Revenue and Forecast (2016-2027)

Chapter 10.      Global Clinical Trial Imaging Services Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, by Service Type (2016-2027)

10.1.2.  Market Revenue and Forecast, by End User (2016-2027)

10.1.3.  Market Revenue and Forecast, by Therapeutic Area (2016-2027)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, by Service Type (2016-2027)

10.1.4.2.      Market Revenue and Forecast, by End User (2016-2027)

10.1.4.3.      Market Revenue and Forecast, by Therapeutic Area (2016-2027)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, by Service Type (2016-2027)

10.1.5.2.      Market Revenue and Forecast, by End User (2016-2027)

10.1.5.3.      Market Revenue and Forecast, by Therapeutic Area (2016-2027)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, by Service Type (2016-2027)

10.2.2.  Market Revenue and Forecast, by End User (2016-2027)

10.2.3.  Market Revenue and Forecast, by Therapeutic Area (2016-2027)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, by Service Type (2016-2027)

10.2.4.2.      Market Revenue and Forecast, by End User (2016-2027)

10.2.4.3.      Market Revenue and Forecast, by Therapeutic Area (2016-2027)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, by Service Type (2016-2027)

10.2.5.2.      Market Revenue and Forecast, by End User (2016-2027)

10.2.5.3.      Market Revenue and Forecast, by Therapeutic Area (2016-2027)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, by Service Type (2016-2027)

10.2.6.2.      Market Revenue and Forecast, by End User (2016-2027)

10.2.6.3.      Market Revenue and Forecast, by Therapeutic Area (2016-2027)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, by Service Type (2016-2027)

10.2.7.2.      Market Revenue and Forecast, by End User (2016-2027)

10.2.7.3.      Market Revenue and Forecast, by Therapeutic Area (2016-2027)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, by Service Type (2016-2027)

10.3.2.  Market Revenue and Forecast, by End User (2016-2027)

10.3.3.  Market Revenue and Forecast, by Therapeutic Area (2016-2027)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, by Service Type (2016-2027)

10.3.4.2.      Market Revenue and Forecast, by End User (2016-2027)

10.3.4.3.      Market Revenue and Forecast, by Therapeutic Area (2016-2027)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, by Service Type (2016-2027)

10.3.5.2.      Market Revenue and Forecast, by End User (2016-2027)

10.3.5.3.      Market Revenue and Forecast, by Therapeutic Area (2016-2027)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, by Service Type (2016-2027)

10.3.6.2.      Market Revenue and Forecast, by End User (2016-2027)

10.3.6.3.      Market Revenue and Forecast, by Therapeutic Area (2016-2027)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, by Service Type (2016-2027)

10.3.7.2.      Market Revenue and Forecast, by End User (2016-2027)

10.3.7.3.      Market Revenue and Forecast, by Therapeutic Area (2016-2027)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, by Service Type (2016-2027)

10.4.2.  Market Revenue and Forecast, by End User (2016-2027)

10.4.3.  Market Revenue and Forecast, by Therapeutic Area (2016-2027)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, by Service Type (2016-2027)

10.4.4.2.      Market Revenue and Forecast, by End User (2016-2027)

10.4.4.3.      Market Revenue and Forecast, by Therapeutic Area (2016-2027)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, by Service Type (2016-2027)

10.4.5.2.      Market Revenue and Forecast, by End User (2016-2027)

10.4.5.3.      Market Revenue and Forecast, by Therapeutic Area (2016-2027)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, by Service Type (2016-2027)

10.4.6.2.      Market Revenue and Forecast, by End User (2016-2027)

10.4.6.3.      Market Revenue and Forecast, by Therapeutic Area (2016-2027)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, by Service Type (2016-2027)

10.4.7.2.      Market Revenue and Forecast, by End User (2016-2027)

10.4.7.3.      Market Revenue and Forecast, by Therapeutic Area (2016-2027)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, by Service Type (2016-2027)

10.5.2.  Market Revenue and Forecast, by End User (2016-2027)

10.5.3.  Market Revenue and Forecast, by Therapeutic Area (2016-2027)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, by Service Type (2016-2027)

10.5.4.2.      Market Revenue and Forecast, by End User (2016-2027)

10.5.4.3.      Market Revenue and Forecast, by Therapeutic Area (2016-2027)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, by Service Type (2016-2027)

10.5.5.2.      Market Revenue and Forecast, by End User (2016-2027)

10.5.5.3.      Market Revenue and Forecast, by Therapeutic Area (2016-2027)

Chapter 11.  Company Profiles

11.1.              BioClinica, Inc.

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Biospective Inc.

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              Calyx

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              ERT Clinical

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              Icon Plc

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              IXICO plc

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Intrinsic Imaging LLC

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              Imaging Endpoints

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              Micron Inc

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

11.10.           Median Technologies

11.10.1.               Company Overview

11.10.2.               Product Offerings

11.10.3.               Financial Performance

11.10.4.               Recent Initiatives

11.11.           Medpace Inc.

11.11.1.               Company Overview

11.11.2.               Product Offerings

11.11.3.               Financial Performance

11.11.4.               Recent Initiatives

11.12.           Pharmtrace

11.12.1.               Company Overview

11.12.2.               Product Offerings

11.12.3.               Financial Performance

11.12.4.               Recent Initiatives

11.13.           ProScan Imaging.

11.13.1.               Company Overview

11.13.2.               Product Offerings

11.13.3.               Financial Performance

11.13.4.               Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

13.2.              Glossary of Terms

Choose License Type

Checkout Inquiry Sample